Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
Clinical trial NCT01939366 · COMPLETED
Trial details
- NCT number
- NCT01939366
- Sponsor
- Tris Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-27
- Primary completion
- 2015-01-01
- Enrollment
- 699
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.